Global Bioenergies SA (ALGBE.PA)
EUR 0.83
(0.24%)
EUR 0.83
(0.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.89 Million | -10.14 Million | -11.87 Million | -10.68 Million | -10.26 Million | -7.41 Million |
| Net Income | -8.65 Million | -11.98 Million | -11.77 Million | -11.14 Million | -12.74 Million | -13.63 Million |
| Depreciation & Amortization | 1.35 Million | 460.77 Thousand | 1.11 Million | 3.27 Million | 3.61 Million | 3.62 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.1 Million | 1.08 Million | -1.32 Million | -2.99 Million | -972.89 Thousand | 2.76 Million |
| Other non-cash items | 3.21 Million | 288.13 Thousand | 109.11 Thousand | 184.19 Thousand | -170 Thousand | -168.78 Thousand |
| Investing Cash Flow | 887.49 Thousand | -1.93 Million | -2.49 Million | -607.51 Thousand | -240.98 Thousand | -973.98 Thousand |
| Investments in PPE | -329.41 Thousand | -1.95 Million | -2.84 Million | -462.13 Thousand | -236.5 Thousand | -973.98 Thousand |
| Acquisitions | 4000.00 | - | 3500.00 | - | - | - |
| Investment purchases | - | - | -355.21 Thousand | -145.38 Thousand | -4477.00 | - |
| Sales/Maturities of investments | 1.21 Million | 18.02 Thousand | 351.71 Thousand | - | - | - |
| Other Investing Activities | 1.21 Million | 18.02 Thousand | 355.21 Thousand | - | -481.96 Thousand | - |
| Financing Cash Flow | 9.91 Million | -133.66 Thousand | 21.13 Million | 9.48 Million | 17.17 Million | 5.25 Million |
| Debt repayment | -1.61 Million | -970.53 Thousand | -240.77 Thousand | -3.73 Million | -1.11 Million | -2.27 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.53 Million | 405.04 Thousand | 21.37 Million | 5.74 Million | 16.32 Million | 6.06 Million |
| Other Financing Activities | 4.99 Million | 431.82 Thousand | 21.13 Million | 7.47 Million | 1.96 Million | 1.46 Million |
| Accounts receivables | - | -63 Thousand | - | - | - | 106 Thousand |
| Accounts payables | - | - | - | - | - | -1.26 Million |
| Inventory | - | -549 Thousand | - | - | - | -216 Thousand |
| Other working capital | -1.1 Million | 1.7 Million | -1.32 Million | -2.99 Million | -972.89 Thousand | 4.13 Million |
| Cash at beginning of period | 8.76 Million | 20.93 Million | 14.49 Million | 16.55 Million | 10.34 Million | 12.48 Million |
| Cash at end of period | 11.67 Million | 8.76 Million | 20.93 Million | 14.49 Million | 16.55 Million | 9.35 Million |
| Capital Expenditure | -329.41 Thousand | -1.95 Million | -2.84 Million | -462.13 Thousand | -236.5 Thousand | -973.98 Thousand |
| Effect of forex changes on cash | - | 53.08 Thousand | -329.86 Thousand | -252.83 Thousand | 1218.00 | - |
| Net cash flow / Change in cash | 2.9 Million | -12.16 Million | 6.44 Million | -2.06 Million | 6.2 Million | -3.13 Million |
| Free Cash Flow | -8.22 Million | -12.1 Million | -14.72 Million | -11.14 Million | -10.5 Million | -8.39 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.78 Million | -8.65 Million | -4.57 Million | -4.08 Million | -11.98 Million | -6.22 Million |
| Depreciation & Amortization | 1.93 Million | 1.35 Million | 727.68 Thousand | 675.02 Thousand | 460.77 Thousand | 315.6 Thousand |
| Deferred income taxes | - | - | 1.00 | -1.00 | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -996.31 Thousand | -1.1 Million | 1.23 Million | -2.33 Million | 1.08 Million | 2.99 Million |
| Other non-cash items | 202.68 Thousand | 3.21 Million | 206.84 Thousand | 1.6 Million | 288.13 Thousand | 736.05 Thousand |
| Investing Cash Flow | -431.33 Thousand | 887.49 Thousand | 284.65 Thousand | 602.83 Thousand | -1.93 Million | -866.65 Thousand |
| Investments in PPE | -431.67 Thousand | -329.41 Thousand | -214.88 Thousand | -114.53 Thousand | -1.95 Million | -884.67 Thousand |
| Acquisitions | 337.00 | 4000.00 | 4000.00 | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 1.21 Million | 495.54 Thousand | 717.37 Thousand | 18.02 Thousand | 18.02 Thousand |
| Other Investing Activities | 1.00 | 1.21 Million | 499.54 Thousand | 717.37 Thousand | 18.02 Thousand | 18.02 Thousand |
| Financing Cash Flow | -2.08 Million | 9.91 Million | 3.93 Million | 5.97 Million | -133.66 Thousand | 583.93 Thousand |
| Debt repayment | -778.96 Thousand | -1.61 Million | -1.36 Million | -244.18 Thousand | -970.53 Thousand | -156.2 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 6.53 Million | 30.34 Thousand | 6.5 Million | 405.04 Thousand | 308.3 Thousand |
| Other Financing Activities | -2.86 Million | 4.99 Million | 3.93 Million | -283.19 Thousand | 431.82 Thousand | 431.82 Thousand |
| Accounts receivables | - | - | - | - | -63 Thousand | -63 Thousand |
| Accounts payables | - | - | - | - | - | 2.06 Million |
| Inventory | - | - | - | - | -549 Thousand | -549 Thousand |
| Other working capital | -996.31 Thousand | -1.1 Million | 1.23 Million | -2.33 Million | 1.7 Million | 2.99 Million |
| Cash at beginning of period | 11.67 Million | 8.76 Million | 9.85 Million | 8.76 Million | 20.93 Million | 11.7 Million |
| Cash at end of period | 7.51 Million | 11.67 Million | 11.67 Million | 9.85 Million | 8.76 Million | 8.76 Million |
| Capital Expenditure | -431.67 Thousand | -329.41 Thousand | -214.88 Thousand | -114.53 Thousand | -1.95 Million | -884.67 Thousand |
| Effect of forex changes on cash | - | - | - | 8.76 Million | 53.08 Thousand | -8.76 Million |
| Net cash flow / Change in cash | -4.15 Million | 2.9 Million | 1.81 Million | 1.08 Million | -12.16 Million | -2.93 Million |
| Free Cash Flow | -2.07 Million | -8.22 Million | -2.61 Million | -5.6 Million | -12.1 Million | -3.69 Million |
WEGE
OI
WFICF
GHON
IHRT
CAVR